514 Episodes

  1. S9 Ep39: FDA Approval Insights: Adjuvant Nivolumab in Completely Resected Stage IIB/C Melanoma

    Published: 11/6/2023

  2. S9 Ep38: Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

    Published: 10/30/2023

  3. S9 Ep37: Naumann Discusses Notable Research Efforts in Endometrial Cancer

    Published: 10/26/2023

  4. S9 Ep36: Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection

    Published: 10/23/2023

  5. S9 Ep35: Hasanuma Highlights the Benefits of Building Authentic Connections Through Mentorship

    Published: 10/19/2023

  6. S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia

    Published: 10/16/2023

  7. S9 Ep33: Gutierrez and Leslie Discuss Recent Efforts and Future Advances in CAR T-Cell Therapy

    Published: 10/12/2023

  8. S9 Ep32: Expert Insights on the United States Chemotherapy Shortage

    Published: 10/9/2023

  9. S9 Ep31: FDA Approval Insights: First-Line Luspatercept for Anemia in Lower-Risk MDS

    Published: 10/5/2023

  10. S9 Ep30: Richardson Reviews Findings and Future Directions With Mezigdomide Plus Dexamethasone in R/R Myeloma

    Published: 10/2/2023

  11. S9 Ep29: Garcia-Manero and Zeidan Highlight Key Implications of the COMMANDS Trial in Lower-Risk MDS

    Published: 9/28/2023

  12. S9 Ep28: FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma

    Published: 9/21/2023

  13. S9 Ep27: Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

    Published: 9/18/2023

  14. S9 Ep26: Chuong Discusses the Importance of MRI-Guided Radiotherapy in Cancer

    Published: 9/14/2023

  15. S9 Ep25: Fonkoua Sheds Light on Liver Cancer Clinical Trial Disparities

    Published: 9/11/2023

  16. S9 Ep24: FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma

    Published: 9/7/2023

  17. S9 Ep23: Usmani Highlights the Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

    Published: 9/4/2023

  18. S9 Ep22: Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC

    Published: 8/31/2023

  19. S9 Ep21: FDA Approval Insights: Dostarlimab Plus Chemotherapy in dMMR/MSI-H Advanced Endometrial Cancer

    Published: 8/28/2023

  20. S9 Ep20: FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML

    Published: 8/21/2023

15 / 26